Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-13 Purchase |
2025-03-14 07:27 am |
Altimmune Inc. | ALT | WEAVER GREGORY L Chief Financial Officer |
10,000 | $5.1996 | $51,996 | 10,000 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 4:01 pm |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Former EVP, CFO, & Director |
50,000 | $0.65 | $32,500 | 55 (Direct) |
View |
| 2023-06-20 Purchase |
2023-06-20 8:15 pm |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L EVP & CFO |
50,000 | $0.97 | $48,500 | 50,055 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-07 4:29 pm |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
107,497 | $5.58 | $599,833 | 0 (Direct) |
View |
| 2021-06-22 Purchase |
2021-06-24 4:15 pm |
ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer |
4,666 | $15 | $69,990 | 4,666 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-11 Option Award |
2024-11-12 4:50 pm |
N/A 2034-11-11 |
Altimmune Inc. | ALT | WEAVER GREGORY L Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 09:00 am |
N/A 2033-06-01 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L EVP & CFO |
2,600,000 | $0 | 2,600,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-05 7:36 pm |
N/A 2033-05-04 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 6:19 pm |
N/A 2032-05-13 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 3:56 pm |
N/A 2032-03-01 |
ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer |
228,000 | $0 | 228,000 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
164,581 | $0 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
4,581 | $5.64 | 0 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
57,084 | $6.4 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
70,000 | $1.7 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
45,000 | $2.52 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
45,000 | $2.38 | 0 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 4:20 pm |
N/A 2031-06-17 |
ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer |
67,726 | $0 | 67,726 (Direct) |
View |
Ownership |
2021-06-17 6:08 pm |
N/A 2025-08-20 |
ATAI Life Sciences B.V. | ATAI | WEAVER GREGORY L Chief Financial Officer |
0 | $0 | 880,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:16 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 2:06 pm |
N/A 2030-05-15 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
70,000 | $0 | 70,000 (Direct) |
View |